Secukinumab Provides Greater Skin Clearance and Improvement in Skin-Related Quality of Life Than Ustekinumab for Biologic-Naive Patients With Psoriasis: Results From the CLEAR 52-Week Study
Document Type
Abstract
Publication Date
June 2017
Journal Title
Journal of the American Academy of Dermatology
Department
Dermatology
Disciplines
Medicine and Health Sciences
Recommended Citation
Gottlieb, A., Lebwohl, M., Gilloteau, I., Zhou, Y., Guana, A., Sherif, B., & Puig, L. (2017). Secukinumab Provides Greater Skin Clearance and Improvement in Skin-Related Quality of Life Than Ustekinumab for Biologic-Naive Patients With Psoriasis: Results From the CLEAR 52-Week Study. Journal of the American Academy of Dermatology, 76 (6 Suppl. 1), AB231. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/46
COinS
